Sofia, S. N. (2025) “Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional class of patients with pulmonary hypertension: A randomized, double-blind, placebo-controlled trial”, Narra J, 5(1), p. e1301. doi: 10.52225/narra.v5i1.1301.